An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is an open-label, multicenter, extension study for subjects who completed
NeurogesX Study C111 and received treatment with NGX-4010 (Capsaicin Patch) within 12 weeks
(up to +7days) before entry into Study C114